Assessment of Bleeding Risk and Cerebrovascular Events in Bipolar Disorder Patients With Atrial Fibrillation on Warfarin Versus Rivaroxaban
No abstract available
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
More News: Atrial Fibrillation | Bipolar | Bleeding | Coumadin | Drugs & Pharmacology | Mania | Warfarin